Predictors of In-Hospital Mortality in Patients with Acute Coronary Syndrome in Hasan Sadikin Hospital, Bandung, Indonesia: A Retrospective Cohort Study

Miftah Pramudyo, Achmad Fauzi Yahya, Erwan Martanto, Badai B Tiksnadi, Giky Karwiky, Raissa Rafidhinar, Gemi Nastiti Indi Putri


Background: Acute coronary syndrome (ACS) is a world health problem with a high mortality rate and is expected to continue to rise in number. The high ACS mortality rate in the hospital is influenced by demographic characteristics, cardiovascular risk factors, clinical presentation, and management. This study aimed to determine the predictors of ACS death at Dr. Hasan Sadikin Hospital Bandung as the highest referral center in West Java. Methods: This study is a retrospective cohort study on all ACS patients undergoing treatment at Dr. Hasan Sadikin Hospital Bandung from January 2018 to December 2019. Multivariate analysis was performed using a logistic regression test with the backward method to assess predictors of patient outcomes. Results: This study involved 919 patients with the in-hospital mortality rate was 10.6%. Multivariate analysis showed that age >65 years was a demographic factor that play a role as a predictor of mortality mortality (AOR 2.143; 95% CI = 1.079-4.256; p = 0.030). Clinical presentation of cardiac arrest arrest (AOR 48.700; 95% CI =14.289-165.980; p<0.001), SBP <90 mmHg (AOR: 4.972; 95% CI =1.730-14.293; p=0.003, heart rate >100 beats per minute (AOR 4.285; 95% CI =2.209-8.310; p<0,001), cardiogenic shock (AOR: 5.433; 95% CI= 2.257-13.074; p<0.001). Cardiovascular management can reduce the risk of in-hospital mortality. Multivariate analysis showed statins (AOR 0.155; 95% CI=0.040-0.594; p=0.007), beta blockers (AOR 0.304; 95% CI=0.162-0.570; p<0,001) and Percutaneous Coronary Intervention (AOR 0.352; 95% CI=0.184-0.673; p=0.002) significantly reduce in-hospital mortality. Interestingly, smoking is associated with a lower mortality rate (OR 0.387; p <0.001). Conclusion: Clinical presentation of cardiac arrest has the highest risk of death, the sequence is cardiogenic shock, heart rate >100 beats per minute, and age >65 years. Administration of statins, beta-blockers, PCI, and smoking are factors that reduce the risk of death.


Hospital death; predictor; acute coronary syndrome


WHO. WHO Fact sheets, 2017. from: Fact sheets, 2017.

Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II trial substudy. Circulation. 2000;102:2031–7.

Fox KAA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). British Medical Journal. 2006;333:1091–4.

Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/Non–ST elevation MIA method for prognostication and therapeutic decision making. JAMA. 2000;284:835–42.

André R, Bongard V, Elosua R, et al. International differences in acute coronary syndrome patients’ baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study. Heart. 2014;100:1201–7.

Ohira T, Iso H. Cardiovascular disease epidemiology in Asia–an overview. Circulation Journal. 2013;CJ-13.

Kiatchoosakun S, Wongvipaporn C, Buakhamsri A, et al. Predictors of in-hospital mortality in non-ST elevation acute coronary syndrome in Thai acute coronary syndrome registry (TACSR). J Med Assoc Thai. 2007;90:41–50.

Chan MY, Du X, Eccleston D, et al. Acute coronary syndrome in the Asia-Pacific region. International Journal of Cardiology. 2016;202:861–9.

McNamara RL, Kennedy KF, Cohen DJ, et al. Predicting in-hospital mortality in patients with acute myocardial infarction. Journal of the American College of Cardiology. 2016;68:626–35.

Peterson ED, Shah BR, Parsons L, et al. Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. American Heart Journal. 2008;156:1045–55.

Kontos MC, Rennyson SL, Chen AY, Alexander KP, Peterson ED, Roe MT. The association of myocardial infarction process of care measures and in-hospital mortality: a report from the NCDR®. American Heart Journal. 2014;168:766–75.

Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). European Heart Journal. 2002;23:1190–201.

dos Santos ES, Minuzzo L, Pereira MP, et al. Acute coronary syndrome registry at a cardiology emergency center. Arq Bras Cardiol. 2006;87:597–602.

Mohanan PP, Mathew R, Harikrishnan S, et al. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J. 2013;34:121–9.

Isezuo S, Sani MU, Talle A, et al. Registry for acute coronary events in Nigeria (RACE-Nigeria): Clinical characterization, management, and outcome. J Am Heart Assoc. 2022;11:e020244.

Yang HY, Ahn MJ, Jeong MH, et al. Predictors of in-hospital mortality in korean patients with acute myocardial infarction. Chonnam Medical Journal. 2019;55:40–6.

Avezum A, Makdisse M, Spencer F, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). American Heart Journal. 2005;149:67–73.

Morrow DA. Myocardial infarction: A companion to Braunwald’s heart disease e-book. Elsevier Health Sciences; 2016.

Hirakawa Y, Masuda Y, Uemura K, Kuzuya M, Kimata T, Iguchi A. Differences in inhospital mortality between men and women with acute myocardial infarction undergoing percutaneous coronary intervention in Japan: Tokai Acute Myocardial Infarction Study (TAMIS). American Heart Journal. 2006;151:1271–5.

Gong IY, Goodman SG, Brieger D, et al. GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome. Int J Cardiol. 2017;244:24–9.

Kosuge M, Kimura K, Kojima S, et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circulation Journal. 2007;72:521–5.

Steinberg BA, Cannon CP, Hernandez AF, et al. Medical therapies and invasive treatments for coronary artery disease by body mass: the “obesity paradox” in the Get With The Guidelines database. The American Journal of Cardiology. 2007;100:1331–5.

Niedziela J, Hudzik B, Niedziela N, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Springer; 2014.

Aune E, Røislien J, Mathisen M, Thelle DS, Otterstad JE. The “smoker’s paradox” in patients with acute coronary syndrome: a systematic review. BMC Med. 2011;9:97.

Zahger D, Cercek B, Cannon CP, et al. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial). Am J Cardiol. 1995;75:232–6.

Grines CL, Topol EJ, O’Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 1995;91:298–303.

Sambola A, Osende J, Hathcock J, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003;107:973–7.

Aune E, Røislien J, Mathisen M, Thelle DS, Otterstad JE. The” smoker’s paradox” in patients with acute coronary syndrome: a systematic review. BMC Medicine. 2011;9:1–11.

Lazzeri C, Valente S, Chiostri M, Attana P, Picariello C, Gensini GF. Impact of hypertension on short-and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes. Heart and Vessels. 2012;27:370–6.

Cecchi E, D’Alfonso MG, Chiostri M, et al. Impact of hypertension history on short and long-term prognosis in patients with acute myocardial infarction treated with percutaneous angioplasty: comparison between STEMI and NSTEMI. High blood pressure & cardiovascular prevention. 2014;21:37–43.

Erne P, Radovanovic D, Schoenenberger AW, et al. Impact of hypertension on the outcome of patients admitted with acute coronary syndrome. Journal of Hypertension. 2015;33:860–7.

McManus DD, Aslam F, Goyal P, Goldberg RJ, Huang W, Gore JM. Incidence, prognosis, and factors associated with cardiac arrest in patients hospitalized with acute coronary syndromes (the Global Registry of Acute Coronary Events Registry). Coronary Artery Disease. 2012;23:105.

Disegni E, Goldbourt U, Reicher-Reiss H, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. J Clin Epidemiol. 1995;48:1197–205.

Hjalmarson Å, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial infarction. The American Journal of Cardiology. 1990;65:547–53.

Jensen MT, Pereira M, Araujo C, et al. Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study. European Heart Journal: Acute Cardiovascular Care. 2018;7:149–57.

Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–53.

Asaad N, El-Menyar A, AlHabib KF, et al. Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome. Acute Cardiac Care. 2014;16:49–56.

Stenestrand U, Wijkman M, Fredrikson M, Nystrom FH. Association between admission supine systolic blood pressure and 1-year mortality in patients admitted to the intensive care unit for acute chest pain. JAMA. 2010;303:1167–72.

Pitsavos C, Panagiotakos D, Zombolos S, et al. Systolic blood pressure on admission predicts in‐hospital mortality among patients presenting with acute coronary syndromes: The Greek study of acute coronary syndromes. The Journal of Clinical Hypertension. 2008;10:362–6.

Wu AH, Parsons L, Every NR, Bates ER. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). Journal of the American College of Cardiology. 2002;40:1389–94.

El-Menyar A, Zubaid M, Almahmeed W, et al. Killip classification in patients with acute coronary syndrome: Insight from a multicenter registry. American Journal of Emergency Medicine. 2012.

Andersson C, Shilane D, Go AS, et al. Beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. Journal of the American College of Cardiology. 2014;64:247–52.

Radovanovic D, Erne P, Schilling J, Noseda G, Gutzwiller F. Association of dyslipidemia and concomitant risk factors with in-hospital mortality in acute coronary syndrome in Switzerland. Heart Drug. 2005;5:131–9.

González-Pacheco H, Vargas-Barrón J, Vallejo M, et al. Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. Therapeutics and Clinical Risk Management. 2014;10:815.

Aronow HD, Topol EJ, Roe MT, et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. The Lancet. 2001;357:1063–8.

Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39:119–77.

Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. European Heart Journal. 2019;40:2671–83.

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.